Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Filings indexed 1,611 across all filing types
Latest filing 2021-06-11 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
本公司依金管會指示停止召開原訂股東會 (補充延期發放紀念品相關事宜)
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (杏輝) regarding the postponement of its originally scheduled shareholders' meeting due to regulatory instructions related to the pandemic. It specifies the original and new tentative dates for the meeting and mentions the delay in distribution of commemorative gifts. There is no financial data, no detailed report, no voting results, and no presentation materials. The document is essentially a regulatory announcement about a procedural change in the AGM schedule. Given the short length (748 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS) rather than an AGM Information (AGM-R) or Declaration of Voting Results (DVA).
2021-06-11 Chinese
110年5月背書保證與資金貸與
Regulatory Filings Classification · 90% confidence The document contains financial data related to guarantees and endorsements provided by the company and its subsidiaries, including amounts and limits. It is a short report (615 characters) with tabulated financial information but does not include comprehensive financial statements or detailed analysis. It is not an announcement of a report but a specific financial disclosure about guarantees and endorsements. This type of information typically falls under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other specific categories like Annual Report or Interim Report.
2021-06-09 Chinese
110年5月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 杏輝, with data presented in a tabular format and explanatory notes about accounting standards and reporting practices. The document length is short (772 characters), and it does not contain detailed financial statements or comprehensive analysis. It appears to be a brief financial summary or revenue report rather than a full interim or annual report. There is no indication that this is an announcement of a report publication or a certification. Given the nature of the content and the short length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2021-06-09 Chinese
110年05月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tabular data listing shareholdings of company insiders, including directors, supervisors, general managers, and their family members. It shows changes in shareholdings, types of shares held, and other related information. There is no indication of financial statements, earnings data, or management discussion. The content is focused on insider share transactions and holdings. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2021-06-08 Chinese
110年05月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, and executives, with specific numbers of shares held, pledged shares, and related percentages. It focuses on insider shareholdings and changes, which is characteristic of a Director's Dealing report. There is no indication of financial statements, earnings data, or meeting materials. The document length is about 3,344 characters, which is sufficient for a detailed insider shareholding report. Therefore, the document is best classified as a Director's Dealing (DIRS) filing.
2021-06-08 Chinese
本公司依金管會指示停止召開原訂於110年6月23日股東會
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (杏輝) stating that the originally scheduled Annual General Meeting (AGM) on June 23, 2021 (110/06/23 in ROC calendar) is postponed due to regulatory instructions related to the pandemic. It mentions that the new date will be decided later by the board and announced subsequently. The document does not contain any financial data, detailed report, or presentation materials. It is a regulatory announcement about the postponement of the AGM, not the AGM materials themselves or the voting results. Given the short length (613 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than an AGM Information (AGM-R) or Report Publication Announcement (RPA).
2021-05-20 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.